Cargando…

DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19

IMPORTANCE: There is an unprecedented need to rapidly identify safe and effective treatments for the novel coronavirus disease 2019 (COVID-19). OBJECTIVE: To systematically investigate if any of the available drugs in Electronic Health Record (EHR), including prescription drugs and dietary supplemen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bejan, Cosmin A., Cahill, Katherine N., Staso, Patrick J., Choi, Leena, Peterson, Josh F., Phillips, Elizabeth J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872383/ https://www.ncbi.nlm.nih.gov/pubmed/33564788 http://dx.doi.org/10.1101/2021.02.04.21251169

Ejemplares similares

Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical Datasets
por: Wei, Wei-Qi, et al.
Publicado: (2023)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

Integrating heterogeneous data to facilitate COVID-19 drug repurposing
por: Prieto Santamaría, Lucía, et al.
Publicado: (2022)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

NOD: a web server to predict New use of Old Drugs to facilitate drug repurposing
por: Narwani, Tarun Jairaj, et al.
Publicado: (2021)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
por: Abdulaziz, Leena, et al.
Publicado: (2022)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Emerging target discovery and drug repurposing opportunities in chordoma
por: Freed, Daniel M., et al.
Publicado: (2022)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Drug repurposing: a systematic review on root causes, barriers and facilitators
por: Krishnamurthy, Nithya, et al.
Publicado: (2022)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Identification of repurposed small molecule drugs for chordoma therapy
por: Xia, Menghang, et al.
Publicado: (2013)

Drug repurposing and human parasitic protozoan diseases
por: Andrews, Katherine T., et al.
Publicado: (2014)

Synergistic drug combinations and machine learning for drug repurposing in chordoma
por: Anderson, Edward, et al.
Publicado: (2020)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Drug Repurposing: An Effective Tool in Modern Drug Discovery
por: Kulkarni, V. S., et al.
Publicado: (2023)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Considerations and challenges for sex-aware drug repurposing
por: Fisher, Jennifer L., et al.
Publicado: (2022)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019)

Transcription-based drug repurposing for COVID-19
por: Killick, Richard, et al.
Publicado: (2020)

Leveraging genetic interactions for adverse drug-drug interaction prediction
por: Qian, Sheng, et al.
Publicado: (2019)

LEVERAGING DRUG-DRUG INTERACTIONS FOR PHARMACOLOGICAL EXTENSION OF HEALTHY LIFESPAN
por: Gruber, Jan
Publicado: (2019)

Drug repurposing: a better approach for infectious disease drug discovery?
por: Law, G Lynn, et al.
Publicado: (2013)

Drug repurposing screens and synergistic drug‐combinations for infectious diseases
por: Zheng, Wei, et al.
Publicado: (2017)

Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
por: Bahmad, Hisham F., et al.
Publicado: (2022)

Drug repurposing: An effective strategy to accelerate contemporary drug discovery
por: Zhan, Peng, et al.
Publicado: (2022)

DrugRep: an automatic virtual screening server for drug repurposing
por: Gan, Jian-hong, et al.
Publicado: (2022)

Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2022)

Editorial: Adopting drug repurposing to overcome drug resistance in cancer
por: Shankar, Eswar, et al.
Publicado: (2023)

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
por: van der Pol, Karel H., et al.
Publicado: (2023)

A genome-wide positioning systems network algorithm for in silico drug repurposing
por: Cheng, Feixiong, et al.
Publicado: (2019)

Leveraging PEPFAR for HIV drug equity
por: Hammond, Alessandro, et al.
Publicado: (2023)

Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug–Gene Interactions
por: Groza, Vlad, et al.
Publicado: (2021)

Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
por: Cannon, Matthew, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fq2bcb3tv097cha80hg7n6oi0j